Heidelberg Pharma AG (FSE: WL6)

https://www.heidelberg-pharma.com

WILEX is a biopharmaceutical Company based in Munich, which was founded in 1997 by a team of physicians and oncologists from the Technical University of Munich. WILEX is focused on the development of new cancer therapies based on antibodies and small molecules. The therapeutic approach of WILEX targets the prevention of growth, spread and the metastasis of malignant tumours and the destruction of malig-nant tumours in the body. The portfolio includes both drug and medical product candidates ranging from research to late stage clinical development. Currently the following compounds are in clinical development: WX-G250 (development name: RENCAREX®), WX-671, WX-UK1 and CA9-SCAN. The company's strategy is to develop WILEX into a commercially successful biopharmaceutical company with a broad portfolio of new drugs and medical products for the treatment of cancer. *

	Start	2017-10-18 renamed
	Group	Heidelberg Pharma (Group)
	Predecessor	Wilex AG
	Industry	cancer drug
	Industry 2	antibody-drug conjugate (ADC)
	Person	Schmidt-Brand, Jan (Wilex 201404– CEO before CFO + Heidelberg Pharma 200109– CEO + CFO)
	Person 2	Wilhelm, Olaf Georg (Therawis 201405– Managing Director before Wilex 2001–201403 CEO)

	Region	Ladenburg
	Country	Germany
	Street	22 Gregor-Mendel-Str.
	City	68526 Ladenburg
		Address record changed: 2020-12-12

Basic data	Employees	C: 51 to 100 (2018-11-30)
	Currency	EUR
	Annual sales	4,373,456 (income, total, consolidated (2017/18) 2018-11-30)
	Profit	-11,671,980 (2018-11-30)
	Cash	19,440,352 (2018-11-30)

		* Document for ï¿½About Sectionï¿½:

		Record changed: 2020-12-12

More documents for Heidelberg Pharma (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)